R. Huber
About
In The Last Decade
R. Huber
27 papers receiving 832 citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Pulmonary and Respiratory Medicine 649
- Surgery 142
- Cardiology and Cardiovascular Medicine 128
- Oncology 109
- Radiology, Nuclear Medicine and Imaging 108
Countries citing papers authored by R. Huber
This map shows the geographic impact of R. Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Huber more than expected).
Fields of papers citing papers by R. Huber
This network shows the impact of papers produced by R. Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Huber. The network helps show where R. Huber may publish in the future.
Co-authorship network of co-authors of R. Huber
This figure shows the co-authorship network connecting the top 25 collaborators of R. Huber. A scholar is included among the top collaborators of R. Huber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Huber. R. Huber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) breakdown → | 607 |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 2 | |
| 8 | 2 | |
| 9 | 19 | |
| 10 | 73 | |
| 11 | 2 | |
| 12 | 27 | |
| 13 | Detection of K-ras and p53 mutations in bronchoscopically obtained malignant and non-malignant tissue from patients with non-small cell lung cancer. | 11 |
| 14 | 2 | |
| 15 | 36 | |
| 16 | 1 | |
| 17 | 6 | |
| 18 | 3 | |
| 19 | 1 | |
| 20 | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.